MedTrace Logo

Validation of a Smartwatch for Blood Pressure Monitoring

NCT06627920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2025-02-27

No results posted yet for this study

Summary

Accurate measurement of blood pressure is essential for the assessment of cardiovascular health and the prevention of cardiovascular disease. Smartwatches have emerged as a promising option for continuous monitoring of blood pressure outside the clinical setting. This study aims to validate the use of the smartwatch KC08 for blood pressure measurement, which is a cost-effective and convenient alternative for blood pressure measurement. A cross-sectional study will be conducted with participants aged greater than or equal to18 years. The measurements of blood pressure, heart rate and oxygen saturation will be performed with the smartwatch KC08, the Beurer PO30 pulse oximeter and the Omron M7 BP monitor. The statistical analysis will evaluate the reliability of the devices and compare the measurements of the two devices using different statistical methods.

Conditions

  • Blood Pressure
  • Heart Rate
  • Oxygen Saturation

Interventions

DEVICE

Use of the KC08 smartwatch, Beurer PO30 and Omron M7 BP monitor.

Use of the KC08 smartwatch, Beurer PO30 and Omron M7 BP monitor to estimate blood pressure, heart rate and oxygen saturation.

Sponsors & Collaborators

  • Valladolid University Clinical Hospital. Cardiology Department.

    collaborator UNKNOWN

  • European University Miguel de Cervantes

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-10
Primary Completion
2024-11-21
Completion
2024-11-21

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627920 on ClinicalTrials.gov